A Phase 1/2, Open-label Study of Valemetostat in Combination With Rituximab and Lenalidomide in Relapsed or Refractory Follicular Lymphoma
Clinical trial NCT05683171 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05683171
- Sponsor
- M.D. Anderson Cancer Center
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-05-19
- Primary completion
- 2027-09-30
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.